Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 987 of 5804
-
Diabetes drug tirzepatide tested for type 1 in new trial
Disease control Not yet recruitingThis study will examine the effects of Tirzepatide (TZP), a glucagon-like peptide 1 (GLP1) - gastric inhibitory peptide (GIP) co-agonist, on metabolism in type 1 diabetes (T1D). Research participants with T1D will undergo measures of insulin sensitivity, and hormone levels post-m…
Phase: PHASE2 • Sponsor: Victor Chang Cardiac Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Pancreas removal plus islet transplant: a new option for benign tumors?
Disease control Not yet recruitingThis phase I/II trial assesses the safety and effectiveness of total pancreatectomy with islet cell autotransplantation for the treatment of patients with long-term pancreatic inflammation (chronic pancreatitis) and non-cancerous (benign) pancreatic tumors. Total removal of the p…
Phase: PHASE1, PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Pre-Surgery boot camp may slash cancer surgery risks
Disease control Not yet recruitingIn this prospective, randomized, controlled trial patients undergoing major gastrointestinal cancer surgery will be exercised (intervention group) 4 weeks before surgery with a high-intensity interval training (HIIT). They will also receive a specialized nutrition therapy and psy…
Phase: NA • Sponsor: University Hospital of Cologne • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Pfizer launches early trial of PF-07994525 for Hard-to-Treat myeloma
Disease control Recruiting nowThis is an open-label, dose escalation and dose expansion study evaluating the safety, tolerability, Pharmacokinetic (PK), Pharmacodynamic (PD), and antitumor activity of PF-07994525 in participants with R/R MM. The study will consist of 2 parts: Part 1 (Dose Escalation) will co…
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Blood test may replace needle biopsies for prostate cancer watch
Knowledge-focused Not yet recruitingThe CHAS3 trial studies whether the Stockholm3 blood test can reliably detect if prostate cancer becomes more aggressive in men who are being carefully monitored instead of treated right away (active surveillance). The goal is to see if this test can help doctors safely follow pa…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Can a heated oxygen tube stop lung complications after abdominal surgery?
Prevention Not yet recruitingMajor abdominal surgery is associated with a substantial risk of early postoperative pulmonary complications, including atelectasis, hypoxemia, pneumonia, and increased need for respiratory support. High-flow nasal cannula (HFNC) provides warmed and humidified oxygen at high flow…
Phase: NA • Sponsor: Uijeongbu St. Mary Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:07 UTC
-
Engineered t cells take on brain tumors in first human test
Disease control Not yet recruitingThis is a Phase I Study evaluating the safety and feasibility of IL-8 receptor-modified patient-derived activated CD70 CAR T cells in adult patients with brain metastases from primary cancer, with either newly diagnosed lesions or recurrent or progressive disease after prior ther…
Phase: PHASE1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for EoE patients? drug trial targets those failed by steroids
Disease control Not yet recruitingThe goal of this study is to find out if a medication called upadacitinib can help treat a condition called Eosinophilic Esophagitis (EoE). The main question it aims to answer are: \- Does upadacitinib in addition to topical corticosteroids help reduce EoE disease activity? Pa…
Phase: PHASE2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Can a common cholesterol pill flush out 'forever chemicals' from veterans' bodies?
Disease control Not yet recruitingThe goal of this study is to test the efficacy and feasibility of Colesevelam administration (50% of the recommended dose) to reduce serum PFAS concentration in the Veteran population who have serum PFAS levels that exceed the National Academies Science criteria (PFASsix \> 20 ng…
Phase: PHASE2 • Sponsor: University of Rhode Island • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a saline flush during labor shield newborn brains?
Disease control Not yet recruitingThe AMNIO-BRAIN Trial is a research study looking at whether a simple treatment during labor can help protect a baby's brain. Some newborns develop a condition called hypoxic-ischemic encephalopathy (HIE), which happens when the brain does not get enough oxygen or blood flow. Th…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a tiny skin shot replace harsh full-body immunotherapy for melanoma?
Knowledge-focused Not yet recruitingThis study investigates whether a single intradermal (i.d.) injection of low-dose anti-CTLA-4 (ipilimumab), given at the tumour site, can enhance immune activation when combined with standard intravenous (i.v.) anti-PD-1 therapy in patients with advanced melanoma. While combined …
Phase: PHASE1, PHASE2 • Sponsor: Amsterdam UMC, location VUmc • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Heart surgery without opioids: a safer path to recovery?
Symptom relief Not yet recruitingThe goal of this clinical trial is to compare the effect of opioid-free anesthesia on the intensity of acute and chronic postoperative pain in patients undergoing cardiac surgery. The study will also evaluate the safety of opioid-free anesthesia in this patient population. The m…
Phase: NA • Sponsor: Clinical Centre of Serbia • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Glow-in-the-Dark cancer detector aims to cut repeat breast surgeries
Disease control Not yet recruitingThis is a minimal risk post-market registry study conducted at participating clinical institutions that are utilizing LumiSystem consistent with the U.S. Food and Drug Administration (FDA) approved indication for use to collect data on the use of LumiSystem in a real-world settin…
Sponsor: Lumicell, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug aims to stop IgG4 disease relapses without Long-Term steroids
Disease control Not yet recruitingThe goal of this clinical trial is to learn if IMM0306 works to reduce the risk of disease relapse in participants with IgG4-related disease (IgG4-RD). It will also learn about the safety and tolerability of IMM0306. The main questions it aims to answer are: * Does IMM0306 reduc…
Phase: PHASE2, PHASE3 • Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Engineered immune cells take on Hard-to-Treat kidney cancer
Disease control Recruiting nowCLEAR CAR-T cell injection (ET-970) is an engineered CD70-targeting allogeneic Chimeric Antigen Receptor T-Cell (CAR-T cell). This is a multi-center, single-arm, open-label, early exploratory clinical study. The objective of this study is to evaluate the safety and preliminary ef…
Phase: EARLY_PHASE1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Zapping nerves to ease Post-Mastectomy pain: which target works best?
Symptom relief Not yet recruitingThe aim of this study is to compare the effectiveness of super-voltage pulsed radiofrequency of stellate ganglion and super-voltage pulsed radiofrequency of T2-T3 sympathetic ganglia in the treatment of postmastectomy pain syndrome.
Phase: NA • Sponsor: National Cancer Institute, Egypt • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Simple blood tests could spot liver cancer earlier in diabetics
Disease control Not yet recruitingLiver cancer is a significant malignancy in Taiwan. With the widespread implementation of antiviral therapies, hepatitis B and C-related liver cancer has gradually declined; however, metabolic dysfunction-associated liver cancer continues to increase, particularly among patients …
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New dialysis filter aims to cut inflammation and protect hearts in kidney patients
Disease control Not yet recruitingPatients receiving maintenance hemodialysis are at increased risk of cardiovascular disease, chronic inflammation, endothelial dysfunction, and impaired quality of life. Medium cut-Off (MCO) hemodialysis membranes have been developed to enhance the removal of middle-molecular-wei…
Phase: NA • Sponsor: Gazi University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New study investigates hidden heart risks in cystic fibrosis patients on modern drugs
Knowledge-focused Not yet recruitingCystic fibrosis (CF) is a disease that affects over 11,000 people in the UK. It is a genetic condition that affects many organs including the lungs, pancreas, kidneys and liver. New drugs called "modulators" have meant people with CF are now living much longer. Until recently, he…
Sponsor: Liverpool Heart and Chest Hospital NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Could a daily eating window shield kidneys in diabetes?
Disease control Recruiting nowThis is a clinical trial to assess how time-restricted eating (TRE) may improve kidney health and filtration patients with type 2 diabetes and increased protein content in their urine. All participants will be participating in TRE in which they follow a consistent 8-10 hour eatin…
Phase: PHASE1 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC